UC HEALTH LINE: New Breath Test Can Detect Tummy Troubles
CINCINNATIA persons breath can tell you a lot of things, like whether they are garlic lovers or regularly chew gum.
But according to doctors at the University of Cincinnati, it can also help uncover problems in the gastrointestinal (GI) tract.
Ralph Giannella, MD, and colleagues in the digestive diseases division are now offering hydrogen/methane breath testing at University Hospital to help patients discover whether they have bacterial overgrowth in their small intestines or are lactose or fructose intolerant.
He says University Hospital is the first facility to offer this test in the Cincinnati area.
Our intestines naturally have bacteria, says Giannella, a professor in the digestive diseases division at UC. These bacteria help break down our food which metabolizes into gas.
Using the gases in persons breath can help us determine problems in their GI tract.
Tests can be done for small intestinal bacterial overgrowth (glucose), sugar intolerances (fructose), dairy intolerances (lactose), or intestinal transit time from the mouth to the large intestine (lactulose).
We have each patient breathe into a special plastic bag, and we draw out the air with a syringe, Giannella says. Then, depending on the purpose of the hydrogen/methane breathing test, we have each patient consume a certain sugar mixture and repeat the process.
He says the test takes about four hours. Breath samples are taken and analyzed every 30 minutes, but the patient does not need to be stationary during the test and can return periodically for timed sampling.
There is no blood draw required, he says. This test is completely non-invasive. By the amount of hydrogen measured in a persons breath, we can determine a diagnosis and decide the best way to treat the patient.
Its simple and beneficial.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.